Astrocyte begins dosing in Phase I trial of traumatic brain injury therapy
The trial will evaluate multiple dose levels of AST-004 over six months at a clinical research site in Kistarcsa, Hungary.
Hungary
Latest in
Hungary
Sputnik V shows efficacy against Covid-19-linked death in Hungarian study
The vaccine was 100% efficient against disease linked mortality in people aged 16 to 44 years.
M&As this week: Citoxlab Group, Medical Prognosis Institute, Ardena Holding
Hungarian contract research organisation (CRO) Citoxlab Group has signed an agreement to acquire another Hungary-based CRO named Solvo Biotechnology.